PerampaAIAN
Annals of Indian Academy of Neurology
  Users Online: 2718 Home | About the Journal | InstructionsCurrent Issue | Back IssuesLogin      Print this page Email this page  Small font size Default font size Increase font size
This article has been cited by
1Diagnosis and management of neuromyelitis optica spectrum disorders - An update
Alice Bruscolini,Marta Sacchetti,Maurizio La Cava,Magda Gharbiya,Massimo Ralli,Alessandro Lambiase,Armando De Virgilio,Antonio Greco
Autoimmunity Reviews.2018;17(3)195
[DOI]
2Clinical burden of relapses in aquaporin-4 immunoglobulin G-positive neuromyelitis optica spectrum disorder: A single center cohort analysis
Robert Kadish,Stacey L. Clardy,Minying Royston,Imran Tanvir,Tavan Parker,Joseph Biskupiak,Adrian Kielhorn
Journal of Neuroimmunology.2022;362(3)577761
[DOI]
3Cost effectiveness of rituximab and mycophenolate mofetil for neuromyelitis optica spectrum disorder in Thailand: Economic evaluation and budget impact analysis
Saharat Aungsumart,Metha Apiwattanakul,Massimo Filippi
PLOS ONE.2020;15(2)e0229028
[DOI]
4Evaluating the Economic Burden of Relapses in Neuromyelitis Optica Spectrum Disorder: A Real-World Analysis Using German Claims Data
Rachel K. Knapp,Fränce Hardtstock,Thomas Wilke,Ulf Maywald,Barthold Deiters,Sophie Schneider,Julie Mouchet
Neurology and Therapy.2022;11(1)247
[DOI]
  About this journal 
  Editorial Board 
  Online Submission 
  Current Issue 
  Archives 
  Ahead of print 
  Instructions to Authors 
  Subscription
  Alerting 
  Feedback 

Submit Articles

Alerts

Join us